NCT01094418

Brief Summary

The purpose of this study is to evaluate the distal sensory nerves of the feet, namely, the dorsal sural, medial dorsal cutaneous and medial plantar nerves, in patients with impaired glucose tolerance and diabetes mellitus type 2 and compare these parameters to those from healthy participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2010

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 29, 2010

Completed
Last Updated

March 29, 2010

Status Verified

March 1, 2010

Enrollment Period

8 months

First QC Date

March 22, 2010

Last Update Submit

March 26, 2010

Conditions

Keywords

polyneuropathyNerve conduction studyImpaired glucose tolerance testDiabetes mellitus

Outcome Measures

Primary Outcomes (1)

  • Nerve conduction parameters

    Nerve conduction study (NCS) parameters of the dorsal sural, medial dorsal cutaneous and medial plantar nerves, along with standard NCS of the tibial and peroenal motor, sural, superficial peronea, median and radial sensory nerves.

    NCS performed once, within one day after enrollment

Secondary Outcomes (1)

  • Clinical neuropathic scoring system

    once, at a single point of time, within one day after enrollment,

Study Arms (3)

IGT group

IGT diagnosed by endocrinologist

Other: Nerve conduction studies ( NCS) of the peripheral nerves

DM group

DM diagnosed by endocrinologist and whose primary NCS screening shows SNAP amplitudes of sural and superficial peroneal nerves greater than 10mA DM patients with no previous diagnosis of peripheral polyneuropathy

Other: Nerve conduction studies ( NCS) of the peripheral nerves

Normal healthy participants

Normal health participants with no previous history of DM, IGT, thyroid disorder, hypercholesterolemia, or other condition associated with peripheral polyneuropathy

Other: Nerve conduction studies ( NCS) of the peripheral nerves

Interventions

Standard NCS of the sural, superficial peroneal sensory nerves, peroneal, tibial motor nerves, radial and median sensory nerves, median motor nerves, F-wave studies of the Tibial and median nerves. NCS of the distal sensory nerves; dorsal sural Medial dorsal cutaneous and medial plantar nerves.

Also known as: EMG(Viking )
DM groupIGT groupNormal healthy participants

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

University affiliated medical center

You may qualify if:

  • For the normal healthy control group
  • Healthy participants with normal NCS parameters
  • For the IGT group
  • Men or women aged 20-70 with IGT referred by the department of endocrinology, with FBS 100-126 mg/dl, post 2 hour OTT - 140-200mg/dl,lasting more than one year.
  • Patients willing to undergo NCS.
  • For the DM group
  • Men or women aged 20-70 with DM type II patients referred by the department of endocrinology, with no previous diagnosis of peripheral polyneuropathy and who showed SNAP amplitudes of the sural and superficial peroneal nerves above 10mA.
  • Patients willing to undergo NCS.

You may not qualify if:

  • No previous diagnosis of any systemic condition related to peripheral polyneuropathy (malnutrition, alcoholic hepatitis, diabetes mellitus( normal group)), no previous medication history, such as chemotherapeutics
  • No symptom or sign of peripheral polyneuropathy, no history of tingling sensation, muscle weakness, or gait disturbance
  • Skin lesion or swelling that would interfere with NCS conduction
  • Previous diagnosis or clinical symptoms that would indicate the presence of mononeuropathy or entrapment neuropathy of the lower extremity.
  • Previous trauma episode of the lower extremity
  • History of alcohol ( exceeding alcohol consumption of 170g per week ) or substance abuse,
  • Pregnancy
  • DM group
  • Presence of undiagnosed peripheral polyneuropathy determined by screening of the sural and superficial peroneal nerves.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catholic University of Medicine, College of Medicine, Bucheon St. Mary's Hospital, Department of Rehabilitation Medicine

Bucheon-si, Kyoungido, 420-717, South Korea

Location

MeSH Terms

Conditions

Glucose IntolerancePolyneuropathiesDiabetes Mellitus

Interventions

Zinostatin

Condition Hierarchy (Ancestors)

HyperglycemiaGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

EnediynesAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsDiynesPolyynesAlkynes

Study Officials

  • Geun Young Park, MD, PhD

    College of Medicine, Catholic University of Korea

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 22, 2010

First Posted

March 29, 2010

Study Start

June 1, 2009

Primary Completion

February 1, 2010

Study Completion

February 1, 2010

Last Updated

March 29, 2010

Record last verified: 2010-03

Locations